Project Grant R01DA058777

Award Date 6/1/24
Completion Date 3/31/29
Dollars Obligated $3.3M
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
This Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $613,017 in funding to the University of California, Los Angeles (UCLA) to conduct research on the neurobiological mechanisms linking reinforcement learning and timing. The key objectives of this 5-year research project are to: 1) Examine how the temporal precision of dopamine (DA) reward omission signals and striatal neural dynamics change...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $529,878 to The Children's Hospital Corporation (Boston Children's Hospital) to conduct research on the molecular mechanisms underlying dopamine receptor desensitization and its impact on motivational control. The research aims to establish a new platform for rapidly identifying...
This Project Grant award of $656,073.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to uncover the neural circuit mechanisms that generate dopamine neuron activity and dopamine reward prediction error signals. The research project, awarded to President and Fellows of Harvard College, will combine molecular, genetic, and electrophysiological tools to examine the roles of glutamate and GABA inputs to dopamine neurons in...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $557,736 to the University of Pittsburgh for research on the role of dopamine signals in valence-dependent learning. The research aims to: 1) measure dopamine's spatially segregated functions in valence-dependent associative learning, 2) identify the...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $2,015,823 to Drexel University to conduct research on regulating dopamine transport through allosteric modulation. The key objectives are to: Elucidate the mechanisms of allosteric transporter modulation of the dopamine transporter (DAT) through computational modeling, molecular simulations, and functional/biochemical studies. Evaluate the...
This two-year, $140,108 project grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke will fund research into the co-regulation of striatal dopamine and acetylcholine in associative reward learning. The grantee, The Trustees of Columbia University in the City of New York, will investigate how these two neuromodulators interact to drive associative reward learning processes. Specifically, the researchers will test the hypothesis that striatal...
This federal Project Grant award of $148,568, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to dissect the mechanisms of dopamine transmission and its role in reward-related behaviors. The award aims to advance the mechanistic understanding of how dopamine signaling occurs at the subcellular level, which is critical for motivation, reward learning, and decision-making. The project will explore how...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $481,049 to the University of California, San Diego (UCSD) for research focused on understanding the role of substantia nigra circuits in Parkinson's disease. The key goals of this 5-year research project are to: 1) characterize how substantia nigra pars reticulata (SNr)...
This $629,844 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is supporting research at Duke University to elucidate the function of the ventral tegmental area (VTA) neural circuits and their contribution to the learning and performance of motivated behaviors. The key products and services being delivered under this 5-year grant, which began on May 1, 2025, include: Using advanced techniques like...
This $173,140 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research at the University of California, San Francisco (UCSF) to elucidate the role of neural activity in the degeneration of midbrain dopamine neurons associated with Parkinson's disease. The project aims to utilize novel mouse models to chronically manipulate the...

ROLES FOR DOPAMINE SIGNALING MODES IN STRIATAL CIRCUIT MODULATION AND BEHAVIOR - SUMMARY DOPAMINE CONTROLS MOVEMENT, LEARNING, MOTIVATION AND REWARD, AND CHANGES IN ITS SIGNALING ARE ASSOCIATED WITH DRUG ADDICTION AND PARKINSON'S DISEASE (PD). DOPAMINE OPERATES THROUGH MULTIPLE MODES, INCLUDING TONIC AND PHASIC SIGNALING, AND MECHANISMS OF DOPAMINE IN THE REGULATION OF BEHAVIOR CONTINUE TO BE DEBATED. RECENT STUDIES ON MOVEMENT, FOR EXAMPLE, HAVE SUGGESTED THAT RAPID, PHASIC DOPAMINE TRIGGERS MOVEMENT AND INSTRUCTED MODELS ON THE MOMENT-TO-MOMENT ROLES OF DOPAMINE IN STRIATAL REGULATION. THESE MODELS ARE CONTRASTED BY CLINICAL WORK THAT AIMS AT PROVIDING STABLE DOPAMINE LEVELS FOR PD TREATMENT. THE LONG-TERM GOAL OF THIS PROJECT IS TO DETERMINE MECHANISMS OF DOPAMINE IN THE CONTROL OF BEHAVIOR. WE HYPOTHESIZE THAT DISTINCT DOPAMINE SIGNALING MODES EMPLOY ACTIVITY-DEPENDENT AND -INDEPENDENT RELEASE MECHANISMS FOR PRODUCING TWO-COMPONENT CONTROL OF BEHAVIORAL OUTPUT. SELECT ROLES OF DOPAMINE REQUIRE FIRING ACTIVITY, WHILE MANY PERMISSIVE ROLES CAN BE FULFILLED BY A RELEASE MECHANISM THAT DOES NOT RELY ON ACTION POTENTIAL-FIRING. WE HAVE DEVELOPED MOUSE MUTANTS AND ACUTE MANIPULATIONS TO ABOLISH ACTION POTENTIAL- INDUCED DOPAMINE RELEASE AND RAPID IN VIVO DOPAMINE DYNAMICS. IN THESE MUTANTS, MOVEMENT INITIATION IS UNPERTURBED, AND THE MICE CAN LEARN TO MAKE EASY, BINARY DECISIONS. IN CONTRAST, MOTIVATION, INVIGORATION OF REWARD-ORIENTED BEHAVIOR, AND PREDICTION ERROR-BASED LEARNING ARE IMPAIRED. THESE DATA INDICATE THE NEED FOR A DEPARTURE FROM THE MODEL THAT PHASIC DOPAMINE TRIGGERS MOVEMENT AND JUSTIFY IN-DEPTH ANALYSES OF DOPAMINE IN REINFORCEMENT LEARNING WITH THE NEW APPROACHES WE ESTABLISHED. WE WILL STUDY STRIATAL DOPAMINE MODULATION IN MOVEMENT AND REINFORCEMENT LEARNING. USING THE NEWLY GENERATED TOOLS, WE WILL PURSUE A RANGE OF BEHAVIORAL ASSAYS AND SIMULTANEOUSLY ASSESS IN VIVO DOPAMINE DYNAMICS WITH FLUORESCENT DOPAMINE SENSORS AND NEURAL ACTIVITY WITH CALCIUM INDICATORS. IN AIM 1, WE PROPOSE TO ESTABLISH RELATIONSHIPS BETWEEN DOPAMINE AND STRIATAL OUTPUT DURING MOVEMENT. WE MEASURE DOPAMINE DYNAMICS, DOPAMINE AXON ACTIVITY AND MEDIUM SPINY NEURON ACTIVITY DURING MOVEMENT INITIATION AND TEST FOR THE ROLES OF DOPAMINE RELEASE IN MOVEMENT AND STRIATAL REGULATION. IN AIM 2, WE DISSECT MECHANISMS OF DOPAMINE IN REINFORCEMENT LEARNING. WE PROPOSE A STEP-WISE, SYSTEMATIC APPROACH TO ASSESS THE NECESSITY FOR ACTION POTENTIAL-INDUCED DOPAMINE RELEASE IN PREDICTION ERROR-BASED LEARNING, MOTIVATION, MOTOR SKILL LEARNING, COCAINE SELF-ADMINISTRATION AND DRUG SEEKING. THIS MULTIPLE PI PROJECT BUILDS ON THE EXPERTISE OF PASCAL KAESER, AN EXPERT IN THE BIOLOGY OF DOPAMINE TRANSMISSION, AND NAOSHIGE UCHIDA, AN EXPERT IN BEHAVIORAL DOPAMINE RESEARCH. OUR WORK WILL SOLVE CENTRAL DISCREPANCIES IN MODELS OF DOPAMINE ACTION IN MOVEMENT CONTROL AND WILL LIKELY ESTABLISH ROLES FOR PRECISE DOPAMINE SIGNALING IN REINFORCEMENT LEARNING. THE KNOWLEDGE WE GENERATE MAY ULTIMATELY HELP REVISE STRATEGIES FOR TREATING DISEASES WITH ALTERED DOPAMINE FUNCTION, FOR EXAMPLE DRUG ADDICTION.

Posted 5/29/24, 12:00 AM